🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was designed to confirm the efficacy and safety of ranibizumab (...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-09
Trial ID
NCT00989989
Treatments Being Tested
To investigate ranibizumab's benefit on prevention of early postoperative v...
Status
Unknown
Location
Ningbo Eye Hospital
Start Date
2020-09-01
Trial ID
NCT04464694
Treatments Being Tested
In the prospective monocentric open label trial patients with diabetic macu...
Status
Completed
Location
Chu de Poitiers
Start Date
2011-10
Trial ID
NCT01823965
Treatments Being Tested
The purpose of this study is to evaluate the effects of panretinal photocoa...
Status
Completed
Location
University of São Paulo
Start Date
2009-02
Trial ID
NCT01102946
Treatments Being Tested
This study will assess the efficacy and safety of ranibizumab (intravitreal...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-11
Trial ID
NCT00901186
Treatments Being Tested
This study is designed to evaluate the efficacy of intravitreal Ranibizumab...
Status
Unknown
Location
Samsung Medical Center
Start Date
2009-01
Trial ID
NCT01189526
Treatments Being Tested
We look at a randomized comparative study of 2 FDA approved anti-VEGF agent...
Status
Unknown
Location
Alphavision Augenzentrum
Start Date
2019-06-25
Trial ID
NCT03999125
Treatments Being Tested
The purpose of this study is to determine the effect of ranibizumab for the...
Status
Terminated
Location
Seoul National University Bundang Hospital
Start Date
2013-01
Trial ID
NCT01795209
Treatments Being Tested
The purpose of this study is to determine if additional panretinal photocoa...
Status
Unknown
Location
Multiple Locations
Start Date
2015-08
Trial ID
NCT02522897
Treatments Being Tested
The primary Objective of this study is to evaluate the safety and tolerabil...
Status
Completed
Location
Wilmer Eye Institute at Johns Hopkins University
Start Date
2009-11
Trial ID
NCT01003106